On the other hand, there are some studies showing that IL-6 is a potential inflammatory mediator in NAFLD development and that the hepatic expression of IL-6 positively correlates with the stage of liver inflammation [21,36,37]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.